A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaSatoru Yokoyama, Kevin M. Brown, Michael G. Gartside et al.|Nature|2011Cited by 474
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsLauren G. Aoude, Andrew P. Barbour|Scientific Reports|2020Cited by 44
Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma PatientsLauren G. Aoude, Andrew P. Barbour|Molecular Cancer Research|2021Cited by 35